Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Decreases Escherichia coli M17 - : fluoroquinolone (antibiotic)s |
👶
Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002). Annals of clinical microbiology and antimicrobials (Ann Clin Microbiol Antimicrob ) Vol: 3 Issue Pages: 14 Pub: 2004 Jul 29 Epub: 2004 Jul 29 Authors Jones ME , Draghi DC , Thornsberry C , Karlowsky JA , Sahm DF , Wenzel RP , Html Article Publication |
| Decreases Escherichia coli M17 - : fluoroquinolone (antibiotic)s |
👶
Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001. Antimicrobial agents and chemotherapy (Antimicrob Agents Chemother ) Vol: 47 Issue 5 Pages: 1672-80 Pub: 2003 May Epub: Authors Karlowsky JA , Jones ME , Thornsberry C , Friedland IR , Sahm DF , Html Article Publication |
| Decreases Escherichia coli M17 - : fluoroquinolone (antibiotic)s |
👶
[Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005]. Zhonghua yi xue za zhi (Zhonghua Yi Xue Za Zhi ) Vol: 87 Issue 39 Pages: 2753-8 Pub: 2007 Oct 23 Epub: Authors Yang QW , Xu YC , Chen MJ , Hu YJ , Ni YX , Sun JY , Yu YS , Kong HS , He L , Wu WY , Ye HF , Yang YM , Zhu LN , Guo SH , Ji P , Zhu ZH , Ren JK , Zhang LX , Sun ZY , Zhu XH , Tong MQ , Zhao WS , Mei YN , Liu Y , Zhang ZJ , Duan Q , Li D , Liu PP , Wang J , Han LX , Wang H , Xie XL , Publication |
| Decreases Escherichia coli M17 - : fluoroquinolone (antibiotic)s |
👶
In vitro antimicrobial activity of fluoroquinolones against clinical isolates obtained in 1989 and 1990. Journal of the Formosan Medical Association = Taiwan yi zhi (J Formos Med Assoc ) Vol: 92 Issue 12 Pages: 1040-8 Pub: 1993 Dec Epub: Authors Chen YC , Chang SC , Hsu LY , Hsieh WC , Luh KT , Publication |
| Decreases Escherichia coli M17 - : fluoroquinolone (antibiotic)s |
👶
Sitafloxacin: in bacterial infections. Drugs (Drugs ) Vol: 71 Issue 6 Pages: 731-44 Pub: 2011 Apr 16 Epub: Authors Keating GM , Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.